5-oxo-3-pyrrolidinecarboxamide derivatives as P2X7 modulators

Details for Australian Patent Application No. 2008337506 (hide)

Owner Glaxo Group Limited

Inventors Steadman, Jon Graham Anthony; Walter, Daryl Simon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008337506

PCT Pub. Number WO2009/077559

Priority 0724623.4 18.12.07 GB; 0800839.3 17.01.08 GB

Filing date 17 December 2008

Wipo publication date 25 June 2009

International Classifications

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/077559 Priority application(s): WO2009/077559

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008337508-Compressible decorative paper impregnating agent which can be printed by the inkjet method

2008337482-Anthelmintic agents and their use